Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P O'Callaghan

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Neurotoxicology and Teratology|September 1, 1988
Neurotypic and gliotypic proteins as biochemical markers of neurotoxicityJ P O'Callaghan
Annals of the New York Academy of Sciences|May 28, 1993
Quantitative features of reactive gliosis following toxicant-induced damage of the CNSJ P O'Callaghan
Biomedical and Environmental Sciences : BES|June 1, 1991
Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarkerJ P O'Callaghan
European Journal of Pain (London, England)|January 19, 2002
Evolution of a rational use of opioids in chronic painJ P O'Callaghan
Neurotoxicology|March 14, 1998
Astrocytes: key players in mediation or modulation of neurotoxic responses? Commentary on forum position paperJ P O'Callaghan
Neurotoxicology and Teratology|May 1, 1991
Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISAJ P O'Callaghan
Neurotoxicology|January 1, 1994
A potential role for altered protein phosphorylation in the mediation of developmental neurotoxicityJ P O'Callaghan
Psychopharmacology Bulletin|January 1, 1994
Biochemical analysis of glial fibrillary acidic protein as a quantitative approach to neurotoxicity assessment: advantages, disadvantages and application to the assessment of NMDA receptor antagonist-induced neurotoxicityJ P O'Callaghan
Anaesthesia and Intensive Care|February 1, 1986
Potential hazard of the Concord Resuscitation MaskJ P O'Callaghan
Anaesthesia and Intensive Care|February 1, 1986
The Combibag: an evaluation of a new self-inflating resuscitatorT Cramond, J P O'Callaghan
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Neurotoxicology and Teratology|September 1, 1988
Neurotypic and gliotypic proteins as biochemical markers of neurotoxicityJ P O'Callaghan
Annals of the New York Academy of Sciences|May 28, 1993
Quantitative features of reactive gliosis following toxicant-induced damage of the CNSJ P O'Callaghan
Biomedical and Environmental Sciences : BES|June 1, 1991
Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarkerJ P O'Callaghan
European Journal of Pain (London, England)|January 19, 2002
Evolution of a rational use of opioids in chronic painJ P O'Callaghan
Neurotoxicology|March 14, 1998
Astrocytes: key players in mediation or modulation of neurotoxic responses? Commentary on forum position paperJ P O'Callaghan
Neurotoxicology and Teratology|May 1, 1991
Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISAJ P O'Callaghan
Neurotoxicology|January 1, 1994
A potential role for altered protein phosphorylation in the mediation of developmental neurotoxicityJ P O'Callaghan
Psychopharmacology Bulletin|January 1, 1994
Biochemical analysis of glial fibrillary acidic protein as a quantitative approach to neurotoxicity assessment: advantages, disadvantages and application to the assessment of NMDA receptor antagonist-induced neurotoxicityJ P O'Callaghan
Anaesthesia and Intensive Care|February 1, 1986
Potential hazard of the Concord Resuscitation MaskJ P O'Callaghan
Anaesthesia and Intensive Care|February 1, 1986
The Combibag: an evaluation of a new self-inflating resuscitatorT Cramond, J P O'Callaghan
Pageof 15